Patent · US Active

Process for the preparation of tolerizing immune-modulating particles

US11484506B2 · kind B2 · utility

0Cited by
1References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 21, 2017
Grant dateNov 1, 2022
Priority date
Expiry dateSep 17, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to a method of preparing a pharmaceutical composition comprising tolerizing immune-modulating particles of polymer-encapsulated gliadin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.